Cargando…

N-Methyl-D-Aspartate Encephalitis our Experience with Diagnostic Dilemmas, Clinical Features, and Outcome

INTRODUCTION: A neuropsychiatric syndrome characterized by a wide spectrum of clinical manifestations. It is seen in patients with antibodies against NR1-NR2 heteromers of the NMDA receptor. As the spectrum is mainly psychiatric most patients are treated as psychiatric disease resulting in huge diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, Sadanandavalli R., Padmanabha, Hansashree, Koti, Neeraja, Kalya Vyasaraj, Kishore, Mailankody, Pooja, Pai, Anupama R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413609/
https://www.ncbi.nlm.nih.gov/pubmed/30937083
http://dx.doi.org/10.4103/JPN.JPN_96_18
_version_ 1783402852958339072
author Chandra, Sadanandavalli R.
Padmanabha, Hansashree
Koti, Neeraja
Kalya Vyasaraj, Kishore
Mailankody, Pooja
Pai, Anupama R.
author_facet Chandra, Sadanandavalli R.
Padmanabha, Hansashree
Koti, Neeraja
Kalya Vyasaraj, Kishore
Mailankody, Pooja
Pai, Anupama R.
author_sort Chandra, Sadanandavalli R.
collection PubMed
description INTRODUCTION: A neuropsychiatric syndrome characterized by a wide spectrum of clinical manifestations. It is seen in patients with antibodies against NR1-NR2 heteromers of the NMDA receptor. As the spectrum is mainly psychiatric most patients are treated as psychiatric disease resulting in huge diagnostic delay. PATIENT AND METHODS: Here we describe 29 patients with NMDA encephalitis seen by the authors in the last five years. Percentage of Transfected cells showing granular cytoplasmic florescence was considered for positivity and severity both in CSF and serum. Their presenting diagnosis, clinical features and the dilemmas, alarming gaps, laboratory data, response to treatment and relapses are discussed. OBSERVATIONS: All patients presented with a spectrum of psychiatric symptoms varying from panic to severe aggression, seizures, chorea, hemiplegia, catatonia, mitgehen, mutism, delirium, mania and memory problems. EEG is invariably abnormal as against imaging. CONCLUSION: NMDA receptor mediated encephalitis should be suspected in all children and females of adolescent age with refractory neuropsychiatric syndrome. Both CSF and serum should be tested and regular follow up for relapses and neoplasms is mandatory.
format Online
Article
Text
id pubmed-6413609
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-64136092019-04-01 N-Methyl-D-Aspartate Encephalitis our Experience with Diagnostic Dilemmas, Clinical Features, and Outcome Chandra, Sadanandavalli R. Padmanabha, Hansashree Koti, Neeraja Kalya Vyasaraj, Kishore Mailankody, Pooja Pai, Anupama R. J Pediatr Neurosci Original Article INTRODUCTION: A neuropsychiatric syndrome characterized by a wide spectrum of clinical manifestations. It is seen in patients with antibodies against NR1-NR2 heteromers of the NMDA receptor. As the spectrum is mainly psychiatric most patients are treated as psychiatric disease resulting in huge diagnostic delay. PATIENT AND METHODS: Here we describe 29 patients with NMDA encephalitis seen by the authors in the last five years. Percentage of Transfected cells showing granular cytoplasmic florescence was considered for positivity and severity both in CSF and serum. Their presenting diagnosis, clinical features and the dilemmas, alarming gaps, laboratory data, response to treatment and relapses are discussed. OBSERVATIONS: All patients presented with a spectrum of psychiatric symptoms varying from panic to severe aggression, seizures, chorea, hemiplegia, catatonia, mitgehen, mutism, delirium, mania and memory problems. EEG is invariably abnormal as against imaging. CONCLUSION: NMDA receptor mediated encephalitis should be suspected in all children and females of adolescent age with refractory neuropsychiatric syndrome. Both CSF and serum should be tested and regular follow up for relapses and neoplasms is mandatory. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6413609/ /pubmed/30937083 http://dx.doi.org/10.4103/JPN.JPN_96_18 Text en Copyright: © 2019 Journal of Pediatric Neurosciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Chandra, Sadanandavalli R.
Padmanabha, Hansashree
Koti, Neeraja
Kalya Vyasaraj, Kishore
Mailankody, Pooja
Pai, Anupama R.
N-Methyl-D-Aspartate Encephalitis our Experience with Diagnostic Dilemmas, Clinical Features, and Outcome
title N-Methyl-D-Aspartate Encephalitis our Experience with Diagnostic Dilemmas, Clinical Features, and Outcome
title_full N-Methyl-D-Aspartate Encephalitis our Experience with Diagnostic Dilemmas, Clinical Features, and Outcome
title_fullStr N-Methyl-D-Aspartate Encephalitis our Experience with Diagnostic Dilemmas, Clinical Features, and Outcome
title_full_unstemmed N-Methyl-D-Aspartate Encephalitis our Experience with Diagnostic Dilemmas, Clinical Features, and Outcome
title_short N-Methyl-D-Aspartate Encephalitis our Experience with Diagnostic Dilemmas, Clinical Features, and Outcome
title_sort n-methyl-d-aspartate encephalitis our experience with diagnostic dilemmas, clinical features, and outcome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413609/
https://www.ncbi.nlm.nih.gov/pubmed/30937083
http://dx.doi.org/10.4103/JPN.JPN_96_18
work_keys_str_mv AT chandrasadanandavallir nmethyldaspartateencephalitisourexperiencewithdiagnosticdilemmasclinicalfeaturesandoutcome
AT padmanabhahansashree nmethyldaspartateencephalitisourexperiencewithdiagnosticdilemmasclinicalfeaturesandoutcome
AT kotineeraja nmethyldaspartateencephalitisourexperiencewithdiagnosticdilemmasclinicalfeaturesandoutcome
AT kalyavyasarajkishore nmethyldaspartateencephalitisourexperiencewithdiagnosticdilemmasclinicalfeaturesandoutcome
AT mailankodypooja nmethyldaspartateencephalitisourexperiencewithdiagnosticdilemmasclinicalfeaturesandoutcome
AT paianupamar nmethyldaspartateencephalitisourexperiencewithdiagnosticdilemmasclinicalfeaturesandoutcome